Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Feb 27;12(1):23. doi: 10.1186/1465-9921-12-23

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright ©2011 Mullol et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Additive effect of mometasone and desloratadine on eosinophil survival at day 4. Human epithelial conditioned media (HECM) at 10% (dark grey bars) from nasal mucosa and nasal polyp increased eosinophil survival compared. The combination of mometasone (MF) at 10^-11M and desloratadine (DL) at 10^-5M (striped bars) caused an inhibitory effect higher than MF (light grey bars) or DL (white bars) alone, and similar to MF at 10^-7M. This additive effect was significant when eosinophil survival was induced by nasal mucosa HECM. Results expressed as mean ± SEM of eosinophil survival index. Wilcoxon Signed Rank test was used for statistical comparison. ** p < 0.01, compared to control media; † p < 0.05, compared to HECM. N = 10.